Adults 14 to 18, any sex, with Obesity, Childhood. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Percent Change in BMI in Excess of the 95th Percentile (%BMIp95)Primary· %BMIp95 at Week 12 minus %BMIp95 at baseline
Percent Change in BMI in excess of the 95th percentile (%BMIp95) as calculated by the CDC extended SAS equations at week 12 minus %BMIp95 at baseline.
For example If the BMI is greater than the 95th percentile: BMI percentile equals 90 plus 10 times the cumulative distribution function (CDF) of the standard normal distribution. Sigma is the value from the data table corresponding to the sex of the child and the age in months. and are the cumulative distribution function (CDF) of the standard normal distribution and its inverse function. Standard normal distribution tables can be found in stat
Group
Value
95% CI
LSC + Blinded CGM
-3.27
± 3.34
LSC+TLE + Blinded CGM
-3.76
± 5.76
LSC+TLE+ Real Time Feedback Via CGM
-4.85
± 5.08
Average GlucoseSecondary· Change in average glucose at week 12 minus average glucose at baseline
Affect of TRE on change in average glucose
Group
Value
95% CI
LSC + Blinded CGM
0.5
-20.2 – 6.0
LSC+TLE + Blinded CGM
-7.1
-18.2 – 6.0
LSC+TLE+ Real Time Feedback Via CGM
-4.2
-14.7 – 6.1
Sponsor's own description
The investigators propose a randomized controlled trial in 90 children (age 13-21y) with obesity recruited from clinical programs at the Children's Hospital Los Angeles (CHLA). Patients will be randomized to one of three treatment groups for a 12-week intervention: Group 1) Low sugar and carbohydrate diet (LSC, \<90 gm carbohydrate (CHO)/day, \<25 gm added sugar/day) + blinded CGM (used to monitor adherence and glycemic outcomes without real time feedback). Group 2) LSC+TLE (16-hour fast/8-hour feed for 3 days per week) + blinded CGM, Group 3) LSC+TLE+ real time feedback via CGM (to evaluate effect of providing CGM data on intervention efficacy).
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Children's Hospital Los Angeles
Last refreshed: 4 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03954223.